The development of a patient decision aid to reduce decisional conflict about antidepressant use in pregnancy
- PMID: 35562801
- PMCID: PMC9099318
- DOI: 10.1186/s12911-022-01870-1
The development of a patient decision aid to reduce decisional conflict about antidepressant use in pregnancy
Abstract
Background: People with moderate to severe depression in pregnancy must weigh potential risks of untreated or incompletely treated depression against the small, but uncertain risks of fetal antidepressant drug exposure. Clinical support alone appears insufficient for helping individuals with this complex decision. A patient decision aid (PDA) has the potential to be a useful tool for this population. The objective of our work was to use internationally recognized guidelines from the International Patient Decision Aids Standards Collaboration to develop an evidence-based PDA for antidepressant use in pregnancy.
Methods: A three-phased development process was used whereby, informed by patient and physician perspectives and evidence synthesis, a steering committee commissioned a web-based PDA for those deciding whether or not to start or continue antidepressant treatment for depression in pregnancy (Phase 1). A prototype was developed (Phase 2) and iteratively revised based on feedback during field testing based on a user-centred process (Phase 3).
Results: We developed a web-based PDA for people deciding whether to start or continue antidepressant use for depression in pregnancy. It has five interactive sections: (1) information on depression and treatment; (2) reasons to start/continue an antidepressant and to start/stop antidepressant medication; (3) user assessment of values regarding each issue; (4) opportunity to reflect on factors that contribute to decision making; and (5) a printable PDF that summarizes the user's journey through the PDA.
Conclusions: This tool, which exclusively focuses on depression treatment with Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors, can be used by individuals making decisions about antidepressant use to treat depression during pregnancy. Limitations of the PDA are that it is not for other conditions, nor other medications that can be used for depression, and in its pilot form cannot be used by women who do not speak English or who have a visual impairment. Pending further study, it has the potential to enhance quality of care and patient experience.
Keywords: Antidepressant; Depression; Online; Patient decision aid; Pregnancy.
© 2022. The Author(s).
Conflict of interest statement
SNV and DES report royalties from UpToDate for authorship of materials related to antidepressants in pregnancy. SG reports royalties from UpToDate and Psychotherapy Essentials to Go for authorship of materials related to treatment of depression in pregnancy. DES serves on the Medical Advisory Committee of Lilly’s Cymbalta Pregnancy Registry. The other authors have no conflicts of interest to declare.
Figures
Similar articles
-
A patient decision aid for antidepressant use in pregnancy: study protocol for a randomized controlled trial.Trials. 2016 Feb 29;17(1):110. doi: 10.1186/s13063-016-1233-4. Trials. 2016. PMID: 26923796 Free PMC article. Clinical Trial.
-
A patient decision aid for antidepressant use in pregnancy: Pilot randomized controlled trial.J Affect Disord. 2019 May 15;251:91-99. doi: 10.1016/j.jad.2019.01.051. Epub 2019 Mar 18. J Affect Disord. 2019. PMID: 30913472 Clinical Trial.
-
Decisional conflict among women considering antidepressant medication use in pregnancy.Arch Womens Ment Health. 2014 Dec;17(6):493-501. doi: 10.1007/s00737-014-0448-1. Epub 2014 Aug 9. Arch Womens Ment Health. 2014. PMID: 25104244
-
Effectiveness of patient decision aids in women considering psychotropic medication use during pregnancy: a literature review.Arch Womens Ment Health. 2021 Aug;24(4):569-578. doi: 10.1007/s00737-021-01118-3. Epub 2021 Mar 9. Arch Womens Ment Health. 2021. PMID: 33751206 Review.
-
Antidepressant Treatment of Depression During Pregnancy and the Postpartum Period.Evid Rep Technol Assess (Full Rep). 2014 Jul;(216):1-308. doi: 10.23970/AHRQEPCERTA216. Evid Rep Technol Assess (Full Rep). 2014. PMID: 30313002 Review.
Cited by
-
Comparison of analog and digital patient decision aids for the treatment of depression: a scoping review.Front Digit Health. 2023 Sep 1;5:1208889. doi: 10.3389/fdgth.2023.1208889. eCollection 2023. Front Digit Health. 2023. PMID: 37744684 Free PMC article.
-
Maternal treatment with selective serotonin reuptake inhibitors during pregnancy and delayed neonatal adaptation: a population-based cohort study.Arch Dis Child Fetal Neonatal Ed. 2024 Apr 18;109(3):294-300. doi: 10.1136/archdischild-2023-326049. Arch Dis Child Fetal Neonatal Ed. 2024. PMID: 38071585 Free PMC article.
References
-
- Jarde A, Morais M, Kingston D, Giallo R, MacQueen GM, Giglia L, et al. Neonatal outcomes in women with untreated antenatal depression compared with women without depression: A systematic review and meta-analysis. JAMA Psychiat. 2016;73(8):826–837. doi: 10.1001/jamapsychiatry.2016.0934. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources